{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:49:47Z","timestamp":1783604987608,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejrad.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T17:55:34Z","timestamp":1473875734000},"page":"2036-2041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy Dynamic Contrast Enhanced CT"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-780X","authenticated-orcid":false,"given":"W.M.","family":"Thaiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kloth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"B\u00f6sm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Horger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejrad.2016.09.012_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2016.09.012_bib0010","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/MCG.0b013e31827f0d3d","article-title":"The role of imaging in hepatocellular carcinoma: the present and future","volume":"47","author":"Davarpanah","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ejrad.2016.09.012_bib0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.acra.2008.02.005","article-title":"Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization","volume":"15","author":"Ippolito","year":"2008","journal-title":"Acad. Radiol."},{"issue":"10","key":"10.1016\/j.ejrad.2016.09.012_bib0020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1076-6332(00)80632-7","article-title":"Application of CT in the investigation of angiogenesis in oncology","volume":"7","author":"Miles","year":"2000","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejrad.2016.09.012_bib0025","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1259\/bjr\/18486642","article-title":"Perfusion CT for the assessment of tumour vascularity: which protocol?","volume":"76","author":"Miles","year":"2003","journal-title":"Br. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2016.09.012_bib0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.rcl.2008.11.003","article-title":"Body perfusion CT: technique, clinical applications, and advances","volume":"47","author":"Kambadakone","year":"2009","journal-title":"Radiol. Clin. North Am."},{"issue":"6","key":"10.1016\/j.ejrad.2016.09.012_bib0035","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11547-010-0519-y","article-title":"CT perfusion in solid-body tumours. Part I: Technical issues","volume":"115","author":"Petralia","year":"2010","journal-title":"La Radiol. Med."},{"issue":"9","key":"10.1016\/j.ejrad.2016.09.012_bib0040","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ejrad.2014.05.040","article-title":"Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients","volume":"83","author":"Ippolito","year":"2014","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2016.09.012_bib0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejrad.2012.11.014","article-title":"Dual-energy CT to detect recurrent HCC after TACE: initial experience of color-coded iodine CT imaging","volume":"82","author":"Lee","year":"2013","journal-title":"Eur. J. Radiol."},{"issue":"17","key":"10.1016\/j.ejrad.2016.09.012_bib0050","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.2174\/13816128113199990590","article-title":"VEGF signaling in cancer treatment","volume":"20","author":"Sia","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.ejrad.2016.09.012_bib0055","doi-asserted-by":"crossref","first-page":"e64260","DOI":"10.1371\/journal.pone.0064260","article-title":"Actionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinoma","volume":"8","author":"Kwon","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejrad.2016.09.012_bib0060","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hep.27236","article-title":"Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma","volume":"60","author":"Peng","year":"2014","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"4","key":"10.1016\/j.ejrad.2016.09.012_bib0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejrad.2016.09.012_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.06.019","article-title":"Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma","volume":"367","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ejrad.2016.09.012_bib0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1148\/rg.283055108","article-title":"Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features","volume":"28","author":"Hanna","year":"2008","journal-title":"Radiographics"},{"issue":"1016","key":"10.1016\/j.ejrad.2016.09.012_bib0080","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1259\/bjr\/31999821","article-title":"Validation of motion correction techniques for liver CT perfusion studies","volume":"85","author":"Chandler","year":"2012","journal-title":"Br. J. Radiol."},{"issue":"6","key":"10.1016\/j.ejrad.2016.09.012_bib0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ejrad.2015.02.020","article-title":"Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique","volume":"84","author":"Kaufmann","year":"2015","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2016.09.012_bib0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/RCT.0b013e3182a90ee7","article-title":"Midtreatment evaluation of lymphoma response to chemotherapy by volume perfusion computed tomography","volume":"38","author":"Spira","year":"2014","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"3","key":"10.1016\/j.ejrad.2016.09.012_bib0095","first-page":"138","article-title":"[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]","volume":"8","author":"Remmele","year":"1987","journal-title":"Der Pathologe"},{"issue":"13","key":"10.1016\/j.ejrad.2016.09.012_bib0100","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/sj.onc.1202527","article-title":"VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells","volume":"18","author":"Takahashi","year":"1999","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ejrad.2016.09.012_bib0105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/jcp.2010.085142","article-title":"Prognostic significance and potential therapeutic target of VEGFR-2 in hepatocellular carcinoma","volume":"64","author":"Huang","year":"2011","journal-title":"J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.ejrad.2016.09.012_bib0110","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.humpath.2007.03.002","article-title":"Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver","volume":"38","author":"Nakamura","year":"2007","journal-title":"Hum. Pathol."},{"issue":"9","key":"10.1016\/j.ejrad.2016.09.012_bib0115","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00535-012-0571-6","article-title":"Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT","volume":"47","author":"Inoue","year":"2012","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ejrad.2016.09.012_bib0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/13543784.16.1.83","article-title":"VEGF\/VEGFR signalling as a target for inhibiting angiogenesis","volume":"16","author":"Kiselyov","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.ejrad.2016.09.012_bib0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1148\/radiol.13120220","article-title":"Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment","volume":"267","author":"Grouls","year":"2013","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.ejrad.2016.09.012_bib0130","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.7863\/jum.2012.31.12.1909","article-title":"Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft","volume":"31","author":"Sugimoto","year":"2012","journal-title":"J. Ultrasound Med."},{"issue":"1","key":"10.1016\/j.ejrad.2016.09.012_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11307-014-0764-x","article-title":"Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma","volume":"17","author":"Baron Toaldo","year":"2015","journal-title":"Mol. Imaging Biol. MIB"},{"issue":"3","key":"10.1016\/j.ejrad.2016.09.012_bib0140","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s12032-014-0843-5","article-title":"Prognostic value of serum vascular endothelial growth factor receptor 2 response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"31","author":"Zheng","year":"2014","journal-title":"Med. Oncol. (Northwood, London, England)"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X16302819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X16302819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T08:23:29Z","timestamp":1536395009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X16302819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0720048X16302819"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2016.09.012","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy Dynamic Contrast Enhanced CT","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}